Alk-Abello AS (AKBLF)
22.05
0.00 (0.00%)
USD |
OTCM |
Nov 21, 16:00
Alk-Abello Market Cap: 4.882B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 4.882B |
| November 20, 2024 | 4.882B |
| November 19, 2024 | 4.882B |
| November 18, 2024 | 4.882B |
| November 15, 2024 | 4.882B |
| November 14, 2024 | 5.003B |
| November 13, 2024 | 5.269B |
| November 12, 2024 | 5.269B |
| November 11, 2024 | 5.423B |
| November 08, 2024 | 5.312B |
| November 07, 2024 | 5.312B |
| November 06, 2024 | 5.312B |
| November 05, 2024 | 5.312B |
| November 04, 2024 | 5.312B |
| November 01, 2024 | 5.312B |
| October 31, 2024 | 5.312B |
| October 30, 2024 | 5.312B |
| October 29, 2024 | 5.312B |
| October 28, 2024 | 5.561B |
| October 25, 2024 | 5.561B |
| October 24, 2024 | 5.561B |
| October 23, 2024 | 5.561B |
| October 22, 2024 | 5.561B |
| October 21, 2024 | 5.561B |
| October 18, 2024 | 5.561B |
| Date | Value |
|---|---|
| October 17, 2024 | 5.561B |
| October 16, 2024 | 5.561B |
| October 15, 2024 | 5.561B |
| October 14, 2024 | 5.865B |
| October 11, 2024 | 5.865B |
| October 10, 2024 | 5.865B |
| October 09, 2024 | 5.865B |
| October 08, 2024 | 5.865B |
| October 07, 2024 | 5.865B |
| October 04, 2024 | 5.865B |
| October 03, 2024 | 5.865B |
| October 02, 2024 | 5.865B |
| October 01, 2024 | 5.865B |
| September 30, 2024 | 5.865B |
| September 27, 2024 | 5.983B |
| September 26, 2024 | 5.983B |
| September 25, 2024 | 5.983B |
| September 24, 2024 | 5.983B |
| September 23, 2024 | 5.983B |
| September 20, 2024 | 5.983B |
| September 19, 2024 | 5.445B |
| September 18, 2024 | 5.445B |
| September 17, 2024 | 5.445B |
| September 16, 2024 | 5.445B |
| September 13, 2024 | 5.445B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.924B
Minimum
Jul 07 2023
5.983B
Maximum
Sep 20 2024
3.764B
Average
3.962B
Median
Apr 19 2024
Market Cap Benchmarks
| Genmab AS | 13.12B |
| Ascendis Pharma AS | 7.769B |
| Galecto Inc | 7.625M |
| Evaxion Biotech AS | 8.330M |
| IO Biotech Inc | 47.41M |
Market Cap Related Metrics
| PE Ratio | 42.07 |
| PS Ratio | 6.216 |
| PEG Ratio | 0.4156 |
| Price to Book Value | 6.408 |
| Price to Free Cash Flow | 42.70 |
| Price | 22.05 |
| Earnings Yield | 2.38% |
| PEGY Ratio | 0.4156 |
| Operating PE Ratio | 30.94 |
| Normalized PE Ratio | 42.07 |